arrow
Back
N

Nader Sanai

Barrow Neurological Institute

61H-index
382Paper Count
1.8WCitation Count
Published Papers 153
Publication Date
An early clinical trial of 5-ALA sonodynamic therapy in recurrent high-grade glioma
err2025-11-26
err0
PREAI
errNader Sanai; Artak Tovmasyan; An-Chi Tien; Yu-Wei Chang; Tigran Margaryan; William Knight; Kristin Hendrickson; Jennifer Eschbacher; Jocelyn Harmon; Amy Hong; Wonsuk Yoo; Charuta Furey; Stuart L. Marcus; Lea Alhilali; Igor Barani; Zaman Mirzadeh; Shwetal Mehta
errShare
errSave
Single-nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of CDK4/6 and mTOR inhibition in a Phase 0/1 trial of recurrent high-grade glioma
err2025-11-08
err0
errOAAI
errKevin C Johnson; An-Chi Tien; Jun Jiang; James McNamara; Yu-Wei Chang; Chelsea Montgomery; Anita DeSantis; Leonel Elena-Sanchez; Yoko Fujita; Seongho Kim; Avishay Spitzer; Paul Gabriel; William F Flynn; Elise T Courtois; Amy Hong; Jocelyn Harmon; Yoshie Umemura; Artak Tovmasyan; Jing Li; Shwetal Mehta; Roel G W Verhaak; Nader Sanai; null
errShare
errSave
HDAC inhibition-induced neuronal-like state creates cytoskeletal vulnerabilities in glioblastoma
err2025-11-01
err0
errOAAI
errYangi, Doga Demir; Orndorff, Keely; Prakash, Nithish; Uzunalli, Gozde; Stavnichuk, Mariya; Patel, Sonam; Sanai, Nader; Mehta, Shwetal
errShare
errSave
EVALUATION OF TEAD INHIBITOR, VT3989, TREATMENT IN AGGRESSIVE MENINGIOMA
err2025-11-01
err0
errOAAI
errDesai, Siddhi; McNamara, James; Salisbury, Nicole; Stavnichuk, Mariya; Hayes, Elizabeth; Shivanna, Anilkumar Thaghalli; Patel, Sonam; Fakhoury, Jordan; Sanai, Nader; Tien, An-Chi; Mehta, Shwetal
errShare
errSave
Diverse redox states underpin glioblastoma heterogeneity in preclinical models and patient samples
err2025-11-01
err0
errOAAI
errPatel, Sonam; Margaryan, Tigran; Zhang, Hualin; Shaik, Kamal; Knight, William; Pham, Brian; Stavnichuk, Mariya; Hayes, Elizabeth; Kelley-Wolfe, Kyria; Brownell, Zackariah; Hon, Ruiheng; He, Xu; Chung, Kaitlyn; Sanai, Nader; Mehta, Shwetal; Tien, An-Chi; Tovmasyan, Artak
errShare
errSave
INTEGRATED PHARMACOKINETICS, PHARMACODYNAMICS, AND CLINICAL DATA UPDATE FROM PHASE 0/1 TRIAL FOR BDTX-1535 IN NEWLY-DIAGNOSED AND RECURRENT GLIOBLASTOMA PATIENTS WITH EGFR ALTERATIONS
err2025-11-01
err0
errOAAI
errSanai, Nader; Umemura, Yoshie; Karapetyan, Vahuni; Margaryan, Tigran; Huttenlocher, Dylan; Pham, Brian; Harmon, Jocelyn; Hong, Amy; Tien, An-Chi; Tovmasyan, Artak; Mehta, Shwetal
errShare
errSave
A comprehensive framework for intraoperative mapping and monitoring, and perioperative neurological, linguistic, and outcome assessment in glioma resection: Consensus recommendations from the PIONEER Consortium and RANO resect group
err2025-11-01
err0
errOAAI
errGerritsen, Jasper; Karschnia, Philipp; Bello, Lorenzo; Hervey-Jumper, Shawn; Young, Jacob; Seidel, Kathleen; Satoer, Djaina; Schnell, Oliver; Parsons, Michael; Nahed, Brian; Menna, Grazia; Teske, Nico; Smith, Timothy; Sanai, Nader; Krieg, Sandro; Schucht, Philippe; Broekman, Marike; De Vleeschouwer, Steven; Jakola, Asgeir; Van Den Bent, Martin; Chang, Susan; Vogelbaum, Michael; Vincent, Arnaud; Tonn, Joerg-Christian; Berger, Mitchel
errShare
errSave
The radioprotective effect of a novel brain-penetrant superoxide dismutase mimic on normal brain
err2025-11-01
err0
errOAAI
errZhang, Hualin; Kaplan, Gerold; Molloy, Jennifer; Lexvold, Riley; Sanai, Nader; Mehta, Shwetal; Tien, An-Chi; Tovmasyan, Artak
errShare
errSave
SINGLE-CELL PROFILING REVEALS CELLULAR DIVERSITY AND A STEM-LIKE COMPARTMENT IN SUBEPENDYMOMA
err2025-11-01
err0
errOAAI
errLewis, Erika; Furey, Charuta; Johnson, Kevin; Chung, Kaitlyn; Amin, Samir; Gandhi, Sirin; Rabah, Nicholas; Asher, Anthony; Rabadi, Inad; Fakhoury, Jordan; Tien, An-Chi; Verhaak, Roel; Mehta, Shwetal; Sanai, Nader
errShare
errSave
A phase 0/1 study of PRMT5 inhibitor BMS-986504 in recurrent glioblastoma participants with MTAP deletion
err2025-11-01
err0
PREAI
errSanai, Nader; Umemura, Yoshie; Knight, William; Gonzalez, Nadia; Kandasamy, Murugesh; Zhang, Hualin; Pham, Brian; Harmon, Jocelyn; Hong, Amy; Tien, An-Chi; Tovmasyan, Artak; Mehta, Shwetal
errShare
errSave
A global, open-label, randomized Phase 3 trial evaluating niraparib compared to standard temozolomide therapy in patients with newly diagnosed, MGMT-unmethylated glioblastoma
err2025-11-01
err0
errOAAI
errSanai, Nader; Mehta, Shwetal; Tien, An-Chi; Tovmasyan, Artak; Harmon, Jocelyn; Kennedy, William; Aziez, Amine; Chalmers, Anthony; Khasraw, Mustafa; Lim-Fat, Mary Jane; Minniti, Guiseppe; Sanchez, Juan-Manuel Sepulveda; Touat, Mehdi; Umemura, Yoshie
errShare
errSave
P12.27.B A PHASE 0/1 STUDY OF PRMT5 INHIBITOR BMS-986504 IN RECURRENT GLIOBLASTOMA PARTICIPANTS WITH MTAP DELETED TUMORS.
err2025-10-03
err0
errOAAI
errN Sanai; Y Umemura; W Knight; M Kandasamy; H Zhang; B Pham; J Harmon; A Hong; A Tien; A Tovmasyan; S Mehta
errShare
errSave
PHARMACOKINETICS, PHARMACODYNAMICS AND CLINICAL DATA UPDATE FROM PHASE 0/1 TRIAL FOR BDTX-1535 IN RECURRENT GLIOBLASTOMA PATIENTS WITH EGFR ALTERATIONS.
err2025-10-01
err0
errOAAI
errSanai, N.; Umemura, Y.; Karapetyan, V; Margaryan, T.; Huttenlocher, D.; Pham, B.; Harmon, J.; Hong, A.; Yoo, W.; Tien, A.; Tovmasyan, A.; Mehta, S.
errShare
errSave
A CLINICAL UPDATE OF A FIRST-IN-HUMAN PHASE 0/1 TRIAL OF 5-AMINOLEVULINIC ACID SONODYNAMIC THERAPY (5-ALA SDT) IN RECURRENT GLIOBLASTOMA.
err2025-10-01
err0
errOAAI
errSanai, N.; Tien, A.; Tovmasyan, A.; Chang, Y.; Margaryan, T.; Hendrickson, K.; Eschbacher, J.; Yoo, W.; Harmon, J.; Hong, A.; Quarles, C.; Alhilali, L.; Barani, I; Mirzadeh, Z.; Mehta, S.
errShare
errSave
A MECHANISMS OF RADIOSENSITIZATION AND RESISTANCE FOLLOWING HDAC INHIBITION IN GBM PRECLINICAL MODELS.
err2025-10-01
err0
PREAI
errHisted, S.; Orndorff, K.; Yangi, D.; Chung, K.; Hayes, E.; Kelley-Wolfe, K.; Pham, B.; Uzunalli, G.; Patel, S.; Sanai, N.; Tien, A.; Tovmasyan, A.; Mehta, S.
errShare
errSave
A GLOBAL PHASE 3, OPEN-LABEL, RANDOMIZED-CONTROLLED STUDY FOR NEWLY-DIAGNOSED, MGMT UNMETHYLATED GLIOBLASTOMA, COMPARING NIRAPARIB VS STANDARD OF CARE TEMOZOLOMIDE TREATMENT.
err2025-10-01
err0
errOAAI
errSanai, N.; Mehta, S.; Tien, A.; Tovmasyan, A.; Harmon, J.; Kennedy, W. R.; Aziez, A.; Chalmers, A.; Khasraw, M.; Lim Fat, M.; Minniti, G.; Sepulveda, J. M.; Touat, M.; Umemura, Y.
errShare
errSave
Population Pharmacokinetic Modeling of Total and Unbound Pamiparib in Glioblastoma Patients: Insights into Drug Disposition and Dosing Optimization
err2025-04-16
err0
errOAAI
errWickramasinghe, Charuka; Kim, Seongho; Jiang, Yuanyuan; Bao, Xun; Yue, Yang; Jiang, Jun; Hong, Amy; Sanai, Nader
errShare
errSave
A hitchhiker's guide to cerebrospinal fluid biomarkers for neuro-oncology
err2024-12-30
err0
PREAI
errRiviere-Cazaux, Cecile; Keough, Michael B.; Zuccato, Jeffrey A.; Kumar, Rahul; Schulz, Sebastian; Warrington, Arthur E.; Ruff, Michael W.; Ellingson, Benjamin M.; Sanai, Nader; Campian, Jian L.; Kizilbash, Sani H.; Parney, Ian F.; Zadeh, Gelareh; Khasraw, Mustafa; Kessler, Tobias; Cahill, Daniel P.; Mansouri, Alireza; Burns, Terry C.
errShare
errSave